These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6477140)

  • 1. [Complement activation at low temperature. I. The profile of complement component of patients' sera].
    Yukiyama Y; Yoshida K; Hirose S
    Arerugi; 1984 May; 33(5):275-81. PubMed ID: 6477140
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complement: physiopathology, pharmacology and clinical aspects].
    Orrico A; Auteri A
    Ann Sclavo Collana Monogr; 1985; 2(1-2):3-146. PubMed ID: 3880494
    [No Abstract]   [Full Text] [Related]  

  • 3. [Exploration of the route of complement activation in idiopathic membranoproliferative glomerulonephritis and lupic nephropathy].
    Gutiérrez Millet V; Prieto C; Ortuño MT; Usera G; Jarillo MD; Ruilope LM; Rodicio JL
    Rev Clin Esp; 1978 Nov; 151(3):223-8. PubMed ID: 740997
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activated complement in systemic lupus erythematosus].
    Porcel JM; Ordi J
    Med Clin (Barc); 1991 Feb; 96(4):135-7. PubMed ID: 2023487
    [No Abstract]   [Full Text] [Related]  

  • 5. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary systemic lupus erythematosus: an analysis of 4 cases of uncontrolled hereditary angioedema.
    Khan S; Tarzi MD; Doré PC; Sewell WA; Longhurst HJ
    Clin Immunol; 2007 Apr; 123(1):14-7. PubMed ID: 17098477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of C3PA (properdin factor B) and other complement components in diseases associated with a low C3 level.
    Perrin LH; Lambert PH; Nydegger UE; Miescher PA
    Clin Immunol Immunopathol; 1973 Nov; 2(1):16-27. PubMed ID: 4204416
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitation of the fourth complement component by electrophoresis in agarose gel containing antibodies.
    Laurell AB; Sjöholm A; Johnson U
    Clin Exp Immunol; 1970 Sep; 7(3):423-30. PubMed ID: 4991123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways.
    Ceribelli A; Andreoli L; Cavazzana I; Franceschini F; Radice A; Rimoldi L; Sinico RA; Carlsson M; Wieslander J; Tincani A
    Ann N Y Acad Sci; 2009 Sep; 1173():427-34. PubMed ID: 19758182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus.
    Cacoub P; Frémeaux-Bacchi V; De Lacroix I; Guillien F; Kahn MF; Kazatchkine MD; Godeau P; Piette JC
    Arthritis Rheum; 2001 Aug; 44(8):1836-40. PubMed ID: 11508436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement studies of sera and other biologic fluids.
    Schur PH
    Hum Pathol; 1983 Apr; 14(4):338-42. PubMed ID: 6339363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The complement system and clinical effects of its disorders].
    Siegert CE; van Es LA; Daha MR
    Ned Tijdschr Geneeskd; 1996 Nov; 140(46):2268-73. PubMed ID: 8984378
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complement system: an ingenious biochemical mechanism, a co-participant in the natural defense and a mediator of cell interaction].
    Dias da Silva W; Kipnis TL
    AMB Rev Assoc Med Bras; 1984; 30(3-4):67-72. PubMed ID: 6382459
    [No Abstract]   [Full Text] [Related]  

  • 15. [Investigation of the complement system in clinical practice].
    Frémeaux-Bacchi V; Dragon-Durey MA; Blouin J; Mouthon L; Fridman WH
    Ann Med Interne (Paris); 2003 Dec; 154(8):529-40. PubMed ID: 15037829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum complement determinations in patients with quiescent systemic lupus erythematosus.
    Sullivan KE; Wisnieski JJ; Winkelstein JA; Louie J; Sachs E; Choi R; Veksler E; Goldman D; Petri M
    J Rheumatol; 1996 Dec; 23(12):2063-7. PubMed ID: 8970042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The difference between serum and plasma complement activity in primary renal disease.
    Akagaki Y; Fujiwara Y; Nakanishi I; Orita Y; Ando A; Abe H; Kitamura H; Nagaki K; Inai S
    Clin Nephrol; 1980 Aug; 14(2):75-80. PubMed ID: 7408259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum complement in systemic lupus erythematosus (SLE).
    Asano S; Marumo K; Igaki Y; Toyoizumi E; Okubo M
    Arerugi; 1968 Jul; 17(7):597-609. PubMed ID: 5726584
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progress in clinical methods of complement system analysis and data interpretation].
    Inai S
    Nihon Rinsho; 1988 Sep; 46(9):2046-53. PubMed ID: 3149350
    [No Abstract]   [Full Text] [Related]  

  • 20. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
    Arason GJ; Steinsson K; Kolka R; Víkingsdóttir T; D'Ambrogio MS; Valdimarsson H
    Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.